Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement with LuX-Valve Via the Trans-jugular Vein Approach

NCT06862765 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT06862765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06862765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement with LuX-Valve Via the Trans-jugular Vein Approach
Lead sponsor
Xijing Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
June 30, 2024
Enrollment
340 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

high-surgical risk patients with severe tricuspid regurgitation